Want to see JP:7963 full AI Analyst Report?
7963 Stock Chart & Stats
¥1856.00
¥59.00(3.81%)
At close: 4:00 PM EST
¥1856.00
¥59.00(3.81%)
Day’s Range― - ―
52-Week Range¥1,671.00 - ¥2,282.00
Previous CloseN/A
Volume26.10K
Average Volume (3M)4.09K
Market Cap
¥9.01B
Enterprise Value¥10.73B
Total Cash (Recent Filing)¥3.10B
Total Debt (Recent Filing)¥5.46B
Price to Earnings (P/E)11.5
Beta0.30
Next Earnings
Aug 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.73%
Share Statistics
EPS (TTM)156.37
Shares Outstanding5,104,003
10 Day Avg. Volume2,750
30 Day Avg. Volume4,086
Financial Highlights & Ratios
PEG Ratio0.45
Price to Book (P/B)0.66
Price to Sales (P/S)0.77
P/FCF Ratio-39.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth Re-accelerationRe-accelerating revenue (+7.2% in 2025) signals improving demand and market traction. Sustained top-line momentum over the next 2–6 months supports better utilization of fixed costs, underpins investment capacity, and increases the probability of further margin leverage if growth continues.
Stable Gross MarginsConsistent mid-40% gross margins indicate durable pricing power and cost structure resilience. This stability supports persistent operating profitability even if volumes fluctuate, enabling predictable contribution to operating margins and longer-term planning for R&D or capex allocation.
Improving, Manageable LeverageDeclining leverage improves financial flexibility and reduces interest burden, strengthening the balance sheet. A lower debt ratio enhances capacity to fund working capital, strategic investments, or weather shocks over the medium term without materially increasing refinancing risk.
Bears Say
Weak And Volatile Cash GenerationA sharp drop in operating cash flow and negative free cash flow in 2025 materially weakens liquidity and raises funding-flexibility risk. Persistent cash volatility undermines the firm’s ability to self-fund capex, dividends or M&A and increases reliance on external financing in coming months.
Poor Earnings-to-Cash ConversionLow conversion of reported earnings into cash highlights working-capital or non-cash accrual issues. This structural mismatch constrains real financial flexibility, elevates liquidity risk during downturns, and can force suboptimal capital allocation decisions if not resolved.
Moderate Return On CapitalMid-single-digit ROE indicates only average capital efficiency, limiting long-term value creation absent higher growth or margin expansion. Sustained modest returns constrain the company’s ability to generate excess cash for reinvestment or enhanced shareholder distributions.
7963 FAQ
What was Koken Ltd.’s price range in the past 12 months?
Koken Ltd. lowest stock price was ¥1671.00 and its highest was ¥2282.00 in the past 12 months.
What is Koken Ltd.’s market cap?
Koken Ltd.’s market cap is ¥9.01B.
When is Koken Ltd.’s upcoming earnings report date?
Koken Ltd.’s upcoming earnings report date is Aug 05, 2026 which is in 11 days.
How were Koken Ltd.’s earnings last quarter?
Koken Ltd. released its earnings results on May 08, 2026. The company reported ¥29.4 earnings per share for the quarter, beating the consensus estimate of N/A by ¥29.4.
Is Koken Ltd. overvalued?
According to Wall Street analysts Koken Ltd.’s price is currently Overvalued.
Does Koken Ltd. pay dividends?
Koken Ltd. pays a Annually dividend of ¥35 which represents an annual dividend yield of 2.73%. See more information on Koken Ltd. dividends here
What is Koken Ltd.’s EPS estimate?
Koken Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Koken Ltd. have?
Koken Ltd. has 5,104,003 shares outstanding.
What happened to Koken Ltd.’s price movement after its last earnings report?
Koken Ltd. reported an EPS of ¥29.4 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.516%.
Which hedge fund is a major shareholder of Koken Ltd.?
Currently, no hedge funds are holding shares in JP:7963
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Koken Ltd.
Koken Ltd., along with its subsidiaries, specializes in the production and sale of personal protective equipment for occupational use and products designed to enhance environmental quality throughout Japan. The company organizes its diverse operations into three primary divisions: Mask-Related Business, Environmental-Related Businesses, and Other Businesses. Koken provides advanced clean air solutions such as KOACH, a system for creating pristine zones; KOKENLAMINAR, a push-pull ventilation technology; and LAMIKOACH, an air ventilation system specifically engineered for contamination source control. Its offerings also include IMADEZE, a copper-based lactate antibacterial agent, and a variety of masks for both medical facilities and the general public. Furthermore, Koken supplies sophisticated functional water production systems, encompassing electrolyzed water generators, endoscope washers/disinfectors, blood stain washer kits, portable showers, and magnetically treated water. For industrial safety, the company manufactures a comprehensive range of respirators, including particulate, powered air-purifying, supplied air, chemical cartridge, and gas masks. It also offers respirators for general consumers, equipment vital for accident and disaster preparedness, and other protective gear like clothing, ear plugs, and face shields. Koken Ltd. was established in 1943 and is headquartered in Tokyo, Japan.
Technical Analysis
PHC Holdings Corp.
―
Create Medic Co., Ltd.
―
Techno Medica Co., Ltd.
―
Rion Co., Ltd.
―
Japan Medical Dynamic Marketing, Inc.
―